Tilia × viridis
Tilia × viridis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Tilia × viridis is a specialized plant species notable for the unique chemical profile found within its delicate flowers. These floral components are particularly rich in monoterpenes, including key compounds such as alpha-pinene, beta-pinene, and limonene. To harness these specific aromatic properties, the plant material is often processed using dimethyl ether (DME) extraction methods. This preparation technique allows for the concentration of the volatile oils that define the plant's distinct olfactory character. Understanding this botanical composition is essential for those studying the complex chemical synergy of the Tilia genus.
- Synonyms
- Tilia × Moltkei · Tilia Alba Var. Viridis
- Common names
- Not available
- Family
- Malvaceae
- Distribution
- Not available
- Plant Parts
- Flower
Classification
Synonyms
Tilia × viridis is a botanical hybrid that is frequently identified by several different scientific names. In many botanical records, this plant is listed under the synonym Tilia alba var. viridis. It is also commonly referred to as Tilia × moltkei in various taxonomic databases. Understanding these overlapping names is essential for researchers tracking the specific lineage of this species. These relationships highlight the complex naming conventions often found within the Tilia genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tilia × viridis belongs to the diverse kingdom Plantae, representing a fascinating specimen within the natural world. This specific plant is classified under the class Equisetopsida and falls within the large order Malvales. As a member of the Malvaceae family, it shares structural characteristics with many other well-known flowering plants. Its taxonomic identity is further defined by its placement within the genus Tilia. Understanding these botanical relationships provides essential insight into the evolutionary history of this hybrid species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Malvaceae |
| Genus | Tilia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Identification
Biological Activities
Compounds
Tilia × viridis serves as a significant medicinal plant due to its rich profile of bioactive compounds. Research indicates that the flower extract of this species contains a variety of monoterpenes. Specifically, the plant is known to contain alpha-pinene and beta-pinene within its chemical composition. Furthermore, the presence of limonene is a key feature that contributes to its biological activity. These findings suggest that Tilia × viridis may be a valuable natural source for developing immunomodulatory treatments.
Conditions
Tilia × viridis flower dichloromethane extract demonstrates a selective antiproliferative effect against a lymphoma cell line. Research indicates that the plant's activity is driven by monoterpenes, with limonene identified as a primary active component. This extract specifically targets tumor lymphocytes while showing significantly less impact on normal murine cells. Limonene, in particular, exhibits the most potent activity among the identified monoterpenes in suppressing tumor cell proliferation. Consequently, the species represents a promising source of compounds for potential immunomodulatory and anticancer applications.
Preparations
Tilia × viridis is prepared as a dichloromethane extract (DME) to investigate its biological effects. This specific DME was utilized to study the proliferation of both tumor and normal murine lymphocytes. Through bioguided fractionation of the extract, researchers identified a fraction rich in monoterpenes such as limonene. The resulting DME demonstrated selective antiproliferative activity, particularly through its concentrated monoterpene components. Consequently, the preparation of Tilia × viridis as a DME serves as a method to identify potential immunomodulatory agents.
Parts used
Tilia × viridis contains flowers that serve as a significant source of medicinal compounds. Recent studies have focused on using the dichloromethane extract of these flowers to investigate its effects on lymphocyte proliferation. Research indicates that the extract possesses selective antiproliferative activity against tumor cells while remaining less harmful to normal cells. This biological activity is largely driven by monoterpenes, with limonene identified as a particularly potent component. Consequently, the flowers of Tilia × viridis may represent a valuable natural resource for developing new immunomodulatory treatments.